Login / Signup

Novel, human cell line-derived recombinant factor VIII (Human-cl rhFVIII, Nuwiq® ) in children with severe haemophilia A: efficacy, safety and pharmacokinetics.

A KlukowskaShaji K KumarV VdovinS KnaubM JansenR Liesner
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2015)
These results in paediatric PTPs indicate that Human-cl rhFVIII is effective for the prevention and treatment of bleeds.
Keyphrases
  • endothelial cells
  • induced pluripotent stem cells
  • pluripotent stem cells
  • young adults
  • emergency department
  • intensive care unit
  • early onset